This initiative, now well underway, represents the largest and most complex silkworm gene-engineering project ever undertaken globally. The program builds upon years of proprietary research and ...

In Indian education, imagination is quietly becoming endangered. As institutions chase measurable outcomes, hyper-competitive ...

Let’s say it’s 2036, and scientists are working on a new class of drugs. Today, for instance, pharmaceutical companies use ...

That’s only one problem. Your immune system also has an adaptive system of specialized immune cells and antibodies that attack and destroy invading microbes. This system remembers what those intruders ...

Games Workshop also addressed the belief that all the Custodes are made from the sons of Terran noble houses, as set out by ...

University of Utah Health. Even as the funding landscape grew more uncertain ...

Films based on books take 44% more at the box office in the UK and 53% more worldwide than original screenplays, proving that ...

The first glowing plant was created in 1986, but it has taken 38 years for the technology to be enjoyed in people’s homes and ...

Keeping up with new medical technology is a big deal for anyone working in healthcare. As we get into 2026, it’s pretty clear ...

Scientist He Jiankui will likely go down in history as the first human to genetically engineer another living person. He has ...

Astellas Gene Therapies remains intent on treating X-linked Myotubular Myopathy (XLMTM) through a gene therapy—but instead of AAV-based resamirigene bilparvovec (AT132), Astellas is now partnering ...

GlaxoSmithKline (GSK) has agreed to acquire Rapt Therapeutics for $2.2 billion, the companies said today, in a deal intended to bolster the buyer’s pipeline with Rapt’s ozureprubart (RPT904), a ...